Tag archive for ‘US Food and Drug Administration’
Alkem Laboratories gets Form 483 from US FDA for St. Louis manufacturing facility
By businessnewstoday On Saturday, June 19th, 2021
0 Comments

Alkem Laboratories gets Form 483 from US FDA for St. Louis plant

(adsbygoogle = window.adsbygoogle || []).push({}); Alkem Laboratories said that the US Food and Drug Administration (FDA) has issued Form 483 to the company with two observations. Form 483 More...

Cipla associate Avenue Therapeutics fails to get FDA approval for IV tramadol
By businessnewstoday On Tuesday, June 15th, 2021
0 Comments

Cipla associate Avenue Therapeutics fails to get FDA approval for IV tramadol

Cipla’s step-down associate firm Avenue Therapeutics has failed to get approval from the US Food and Drug Administration (FDA) for IV tramadol as an alternative for reducing the use of conventional opioids in More...

US FDA issues warning letter to Lupin Limited over its manufacturing facility in Somerset, New Jersey
By businessnewstoday On Monday, June 14th, 2021
0 Comments

Lupin Limited gets FDA warning letter for Lupin Somerset site

Indian pharma company Lupin Limited said that it has been issued a warning letter from the US Food and Drug Administration (FDA) for its manufacturing facility in Somerset, New Jersey. The warning letter follows More...

Glenmark Pharmaceuticals gets FDA approval for Theophylline Extended-Release Tablets generic
By businessnewstoday On Friday, June 4th, 2021
0 Comments

Glenmark gets FDA nod for Theophylline Extended-Release Tablets generic

Glenmark Pharmaceuticals has secured final approval from the US Food and Drug Administration (FDA) for Theophylline Extended-Release Tablets, 300 mg, and 450 mg. The Indian pharma company’s Theophylline Extended-Release More...

Amgen LUMAKRAS FDA approval - LUMAKRAS product shot
By businessnewstoday On Saturday, May 29th, 2021
0 Comments

LUMAKRAS FDA approval : Amgen bags approval in KRAS G12C-mutated NSCLC

LUMAKRAS FDA approval : Amgen has bagged accelerated approval from the US Food and Drug Administration (FDA) for LUMAKRAS (sotorasib) for the treatment of a type of non-small cell lung cancer (NSCLC) in adults. The More...

Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets
By businessnewstoday On Saturday, May 29th, 2021
0 Comments

Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets

Cadila Healthcare (also known as Zydus Cadila) said that it has secured final approval from the US Food and Drug Administration (FDA) to market Fluphenazine Hydrochloride Tablets 1 mg, 2.5 mg, 5 mg, and 10 mg. The More...

Natco Pharma gets FDA approval for Lenalidomide Capsules
By businessnewstoday On Monday, May 24th, 2021
0 Comments

Natco Pharma gets FDA approval for Lenalidomide Capsules

Natco Pharma has secured the final approval from the US Food and Drug Administration (FDA) of its abbreviated new drug application (ANDA) for Lenalidomide Capsules, 5mg, 1 Omg, 15mg, and 25mg, and the tentative More...

Unichem Laboratories gets FDA approval for Amitriptyline HCl Tablets USP
By businessnewstoday On Friday, May 21st, 2021
0 Comments

Unichem Laboratories gets FDA approval for Amitriptyline HCl Tablets generic

Unichem Laboratories, an Indian specialty pharma company, said that it has secured abbreviated new drug application (ANDA) approval for its Amitriptyline HCl Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 More...

Alembic Pharmaceuticals gets FDA approval for Lurasidone Hydrochloride Tablets
By businessnewstoday On Friday, May 14th, 2021
0 Comments

Alembic Pharmaceuticals gets FDA approval for Lurasidone Hydrochloride Tablets

Alembic Pharmaceuticals has secured final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, More...

Transcenta gets US FDA clearance for launching phase 1 trial of TST005
By businessnewstoday On Tuesday, April 20th, 2021
0 Comments

Transcenta gets US FDA clearance for launching phase 1 trial of TST005

Transcenta has secured clearance of its investigational new drug (IND) application for TST005 from the US Food and Drug Administration (FDA) for launching a phase I clinical trial of the bi-functional anti-PD-L1/TGF-β More...